Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 12:03 pm Sale |
2024-12-31 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO |
Eventide Asset Management, LLC | 1,234,834 3.730% |
-621,152 (-33.47%) |
Filing History |
| 2025-02-14 11:55 am Purchase |
2024-12-31 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO |
JANUS HENDERSON GROUP PLC JHG |
4,339,254 13.100% |
576,059 (+15.31%) |
Filing History |
| 2025-02-14 09:00 am Sale |
2024-12-31 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO |
Omega Fund VI, L.P. | 1,184,636 3.600% |
-972,987 (-45.10%) |
Filing History |
| 2025-02-13 10:24 am Purchase |
2024-12-31 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO |
Mizuho Financial Group, Inc. | 1,926,931 5.800% |
1,926,931 (New Position) |
Filing History |
| 2025-02-12 09:35 am Sale |
2024-12-31 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO |
Adage Capital Management L.P. | 2,209,615 6.680% |
-388,121 (-14.94%) |
Filing History |
| 2025-02-04 3:45 pm Purchase |
2024-12-31 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO |
BLACKROCK INC BLK |
1,821,966 5.500% |
1,821,966 (New Position) |
Filing History |
| 2024-11-14 5:49 pm Sale |
2024-09-30 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO |
Lundbeckfond Invest A/S | 942,671 2.900% |
-893,288 (-48.66%) |
Filing History |
| 2024-11-14 4:45 pm Purchase |
2024-09-30 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO |
Longitude Capital Partners IV LLC | 2,765,381 8.400% |
198,281 (+7.72%) |
Filing History |
| 2024-11-14 12:32 pm Purchase |
2024-09-30 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO |
JANUS HENDERSON GROUP PLC JHG |
3,763,195 11.400% |
369,908 (+10.90%) |
Filing History |
| 2024-11-14 12:23 pm Sale |
2024-09-30 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO |
Eventide Asset Management, LLC | 1,855,986 5.610% |
-336,225 (-15.34%) |
Filing History |
| 2024-11-12 09:31 am Purchase |
2024-09-30 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO |
Adage Capital Management L.P. | 2,597,736 7.860% |
2,597,736 (New Position) |
Filing History |
| 2024-08-09 09:43 am Sale |
2024-07-31 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO |
Eventide Asset Management, LLC | 2,192,211 6.650% |
-810,620 (-27.00%) |
Filing History |
| 2024-08-05 12:54 pm Purchase |
2024-07-25 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO |
JANUS HENDERSON GROUP PLC JHG |
3,393,287 10.300% |
1,062,549 (+45.59%) |
Filing History |
| 2024-02-14 4:57 pm Sale |
2023-12-31 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO |
Citadel Advisors LLC | 2,084,267 7.800% |
-8,221 (-0.39%) |
Filing History |
| 2024-02-14 4:43 pm Purchase |
2023-12-31 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO |
Omega Fund VI, L.P. | 2,157,623 8.100% |
2,157,623 (New Position) |
Filing History |
| 2024-02-14 4:34 pm Purchase |
2023-12-31 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO |
Lundbeckfond Invest A/S | 1,835,959 6.900% |
1,835,959 (New Position) |
Filing History |
| 2024-02-14 1:43 pm Purchase |
2023-12-31 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO |
JANUS HENDERSON GROUP PLC JHG |
2,330,738 8.700% |
2,330,738 (New Position) |
Filing History |
| 2024-02-14 06:04 am Purchase |
2023-12-31 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO |
D1 Capital Partners L.P. | 2,506,607 9.400% |
2,506,607 (New Position) |
Filing History |
| 2024-02-13 4:43 pm Purchase |
2023-12-31 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO |
Longitude Capital Partners IV LLC | 2,567,100 9.600% |
2,567,100 (New Position) |
Filing History |
| 2023-12-15 4:51 pm Purchase |
2023-12-11 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO |
Novo Holdings A/S | 1,307,829 4.900% |
13,776 (+1.06%) |
Filing History |